期刊文献+

肿瘤抗原联合CD40L致敏树突状细胞诱导CTLs杀伤K562细胞的实验研究 被引量:2

Antigen-loaded dendritic cells and CD40L triggers the killing effects of cytotoxic T lymphocytes on K562 cells in vitro
暂未订购
导出
摘要 目的:以健康人外周血单核细胞为前体细胞,体外诱导为树突状细胞(DCs),负载K562细胞冻融抗原,并联合CD40L诱导产生特异性细胞毒性T淋巴细胞(CTLs)对K562细胞的杀伤作用。方法:密度梯度离心法、贴壁法分离健康人外周血单核细胞,应用rhGM-CSF、rhIL-4、rhTNF-α等细胞因子诱导扩增,培养DCs,用K562细胞冻融抗原联合rhsCD40L致敏DCs。实验分4组:K562细胞冻融抗原致敏DCs为实验组A,联合CD40L致敏DCs为实验组B,未致敏DCs为对照组A,单核细胞+异体淋巴细胞组为对照组B,观察CTLs对K562细胞的杀伤效应。结果:培养出具有典型特征的DCs,表达CD40最高达96%、CD86达97%、CD80为77%、CD1a为69%,体外能诱导强烈的同种异体混合淋巴细胞增殖反应。在效靶比为20∶1时,实验组A对K562细胞的杀伤率为71.3%,实验组B为86.9%,对照组A为37.6%,对照组B为21.1%。实验组均显示高水平杀伤率,与对照组比较差异显著(P<0.05),实验组B加CD40L杀伤率高于实验组A(P<0.05)。结论:K562细胞冻融抗原冲击致敏DCs能有效诱导T细胞特异性抗白血病作用,联合CD40L能增强其CTL的杀伤作用。 AIM : To investigate the anti - tumor effects of special cytotoxic T lymphocytes (CTLs) activated by dendritic cells (DCs) loaded with antigens and CD40L in vitro. METHODS: Peripheral blood mononuclear cells were isolated by Ficoll density gradient centrifugation from normal human heparinized blood. The adherent cells were cultured with granulocyte - macrophage colony stimulating factor ( GM - CSF), interleukin - 4 ( IL - 4 ), alpha tumor necrosis factor (TNF- α), DCs were co -cultured with frozen -thawed antigen of K562 cells and CD40L, then triggered T cells into specific CTLs. RESULTS: Most suspended cells exhibited distinctive morphological features of DCs which expressed CD40 96%, CD86 97%, CD80 77%, CD1a 69%, and gained the powerful capacity to stimulate proliferation of allogenic lymphocytes. Under the effector: target ratio of 20: 1, CTLs derived from cultures with DCs and frozen - thawed antigen of K562 cells were showed 71.3% cytotoxicities against K562 cells. CTLs derived from cultures with DCs loaded with frozen - thawed antigen and CD40L were showed 86.9% cytotoxicities against K562 cells. Cytotoxicities by CTLs derived from cultures with unloaded DCs against K562 cells were 37.6% and cytotoxicities by monocytes were 21.1%. Cytotoxicities by CTLs derived from experiment groups were stronger than control groups (P 〈 0. 05 ). CONCLUSIONS: The tumor antigen -pulsed DCs induces efficient and specific anti - tumor immunity, CTLs derived from cultures containing DCs pulsed with CIMOL show the strongest cytolytic activities on K562 cells.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2006年第9期1751-1755,共5页 Chinese Journal of Pathophysiology
基金 广州市科技计划项目资助(No.2002Z3-E0012)
关键词 树突细胞 冻融抗原 CIMO配体 K562细胞 T淋巴细胞 细胞毒性 Dendritic cells Frozen - thawed antigen CD40 ligand K562 cells T - lymphocytes, cytotoxic
  • 相关文献

参考文献9

  • 1Decker T,Lohmann-Matthes ML.A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity[J].Immunol Methods,1988,115(1):61-69.
  • 2Gervais A,Bouet-Toussaint F,Toutirais O,et al.Ex vivo expansion of antitumor cytotoxic lymphocytes with tumor-associated antigen-loaded dendritic cells[J].Anticancer Res,2005,25(3B):2177-2185.
  • 3Onaitis MW,Kaladv MF,Emani S,et al.CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy[J].Surgery,2003,134(2):300-305.
  • 4Ebstein F,Sapede C,Royer PJ,et al.Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells[J].Am J Respir Crit Care Med,2004,169(12):1322-1330.
  • 5林东军,华佳叶,付咏梅,林曲,黄仁魏,方志刚.WT1多肽致敏树突状细胞诱导杀伤K562细胞实验研究[J].中国病理生理杂志,2005,21(5):923-926. 被引量:1
  • 6Neidhardt-Berard EW,Berard F,Banchereau J,et al.Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes[J].Breast Cancer Res,2004,6 (4):R322-R328.
  • 7Hsu FJ,Benike C,Fagnoni F,et al.Vaccination of patients with B-cell lymphoma using autologous antigenpulsed dendritic cells[J].Nat Med,1996,2 (1):52-58.
  • 8Hoffmann TK,Meidenbauer N,Muller Berghaus J,et al.Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells[J].J Immunother,2001,24(2):162-171.
  • 9Lapointe R,Bellemare-Pelletier A,Housseau F,et al.CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells[J].Cancer Res,2003,63 (11):2836-2843.

二级参考文献11

  • 1Weidmann E, Brieger J, Jahn B, et al. Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia[J]. Ann Hematol, 1995, 70(3): 153-158.
  • 2Curti A. Dendritic cell differentiation from hematopoietic CD34 progeni torcells[J]. Biot Regul Hemeost Agents,2001,15(1):49-52.
  • 3Small EJ, Fratesi P, Reese DM, et al. Immunotherapy of hormonoe-refractory prostate cancer with antigen-loaded dendritic cell[J]. Clin Oncol, 2000, 18(23): 3894-3903.
  • 4Gaiger A, Schmid D, Heinze G, et al. Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in denovo acute myeloid leukemia[J]. Leukemia, 1998, 12(12): 1886-1894.
  • 5Ohminami H, Yasukawa M, Fujita S. HLA class I-restricted lysis of leukemia cells by a CD8+ cytotoxic T-lymphocyte clone specific for WT1 peptide[J]. Blood, 2000, 95(1): 286-293.
  • 6Gao L, Bellantuono I, Elsasser A, et al. Selective elimination of leukemia CD34+ progenitor cells by cytotoxic T lymphocytes specific for WT1[J]. Blood, 2000, 7(1): 2198-2203.
  • 7Syme R, Bryan T, Duggan P, et al. Priming with dendritic cells can generate strong cytotoxic T cell responses to chronic myelogenous leukemia cells in vitro[J]. Stem Cells Dev, 2004, 13(2): 211-221.
  • 8Oka Y, Tsuboi A, Murakami M, et al. Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis[J]. Int J Hematol, 2003, 78(1): 56-61.
  • 9Sugiyama H. Cancer immunotherapy targeting WT protein[J]. Int J Hematol, 2002, 76(2): 127-132.
  • 10Makita M, Hiraki A, Azuma T, et al. Antilung cancer effect of WT1-specific cytotoxic T lymphocytes[J]. Clin Cancer Res, 2002, 8(8): 2626-2631.

同被引文献37

  • 1湛海伦,高新,邱剑光,蔡育彬,司徒杰,温星桥.抗原致敏DC与CIK共培养体外抗肾癌效应的研究[J].中国病理生理杂志,2006,22(10):1993-1996. 被引量:9
  • 2Schnare M, Barton GM, Holt AC, et al. Toll - like receptors control activation of the adaptive immune response [J]. Nat Immunol, 2001,2(10) : 947 -950.
  • 3萨姆布鲁克 J,拉塞尔 D W.分子克隆试验指南[M].第3版.北京:科技出版社,2002.880-887.
  • 4Cella M, Sheidegger D, Palmer - Lehman K, et al. Ligation of CD40 on dendritic cells triggers the production of high levels of interleukin - 12 and enhances T cell stimulatory capacity : T - T help via APC activation [J]. J Exp Med, 1996,184(2) :747 -752.
  • 5Ebner S, Hofer S,Nguyen VA, et al. A novel role for IL-3: human monocytes cultured in the presence of IL - 3 and IL -4 differentiate into dendritic cells that produce less IL - 12 and shift Th cell responses toward a Th2 cytokine pattern [J]. J Immunol,2002,168(12) :6199-6207.
  • 6Nomura F, Akashi S, Sakao Y, et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down - regulation of surface Toll - like receptor 4 expression [J]. J Immunol, 2000,164(7) : 3476 -3479.
  • 7O' Sullivan BJ, Thomas R. CD40 ligation conditions dendritic cell antigen - presenting function through sustained activation of NF - κB [J]. J Immunol, 2002, 168 ( 11 ) : 5491 - 5498.
  • 8Chatila TA. Role of regulatory T cells in human diseases [J]. Allergy Clin Immunol, 2005, 116(5) :949 -959.
  • 9Hock BD, Roberts G, McKenzie JL, et al. Exposure to the electrofusion process can increase the immunogenicity of human cells [J]. Cancer Immunol Immunother, 2005, 54(9) :880 - 890.
  • 10Yagi H, Nomura T, Nakamura K, et al. Crucial role of FOXP3 in the development and function of human CD25 + CD4 + regulatory T cells [ J ]. Int Immunol, 2005, 16 ( 11 ) :1643 - 1656.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部